GSK Gsk Plc

TIDMGSK

RNS Number : 7391C

GlaxoSmithKline PLC

19 April 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ====================================================================== 
 a)   Name                     Ms C Thomas 
===  ========================  ============================================ 
 b)   Position/status          SVP, HR 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 13 April 2017 on released 
                                shares from the Company's 2009 Deferred 
                                Annual Bonus Plan on a post-tax basis - 
                                Co-investment shares and Matching Award. 
===  ========================  ============================================ 
 c)   Price(s) and              Price(s)     Volume(s) 
       volume(s)                -----------  ------------------------------ 
                                 GBP16.4042   41.365 (Co-investment shares) 
                                -----------  ------------------------------ 
                                 GBP16.4042   13.866 (Matching - nil-cost 
                                               option) 
                                -----------  ------------------------------ 
---  ------------------------  -------------------------------------------- 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 55.231 
                                 GBP16.4042 
---  ------------------------  -------------------------------------------- 
 e)   Date of the transaction  2017-04-18 
---  ------------------------  -------------------------------------------- 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
---  ------------------------  -------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLKLFFDZFLBBQ

(END) Dow Jones Newswires

April 19, 2017 08:27 ET (12:27 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024